Patents by Inventor Philip E. Erickson

Philip E. Erickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
    Patent number: 6133276
    Abstract: Ligand inhibitors for increasing levels of free corticotropin-releasing factor (CRF) in the brain are disclosed. Such ligand inhibitors cause release of CRF from the CRF/CRF-bind protein complex. Administration of the ligand inhibitors provide improvement in learning and memory, result in decreased food intake and/or provide treatment for diseases associated with low levels of CRF in the brain, notably Alzheimer's disease.
    Type: Grant
    Filed: December 29, 1998
    Date of Patent: October 17, 2000
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Jeffrey P. Whitten, James R. McCarthy, Zhengyu Liu, Charles Q. Huang, Philip E. Erickson, Dominic P. Behan
  • Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
    Patent number: 5959109
    Abstract: Ligand inhibitors for increasing levels of free corticotropin-releasing factor (CRF) in the brain. Such ligand inhibitors cause release of CRF from the CRF/CRF-binding protein complex. Administration of the ligand inhibitors provide improvement in learning and memory, result in decreased food intake and/or provide treatment for diseases associated with low levels of CRF in the brain, notably Alzheimer's disease.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: September 28, 1999
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Jeffrey P. Whitten, James R. McCarthy, Zhengyu Liu, Charles Q. Huang, Philip E. Erickson, Dominic P. Behan